Investing Profile

Martin Alexander Gershon(23)

CEOInvestorFounderVC

Endeavor Life Science Venture Funds is a Series B evergreen fund and Seed and Series A Venture Studio.

gershoncapital.comNew York, New York

Your Intro Paths to Martin Alexander Gershon

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Martin Alexander is a member of

Techstars Network

484 CONNECTIONS

Columbia University in the City of New York Network

397 CONNECTIONS

Columbia University in the City of New York Network

397 CONNECTIONS

McGill University Network

160 CONNECTIONS

VU Venture Partners Network

80 CONNECTIONS

Find Martin Alexander Gershon on

Current Investing Position

Endeavor Venture Funds Managing Partner

Investment Range

$500K - $25.0M

Sweet Spot

$10.0M

Investments On Record

Martin Alexander Gershon is on these Sector & Stage Rankings

BioTech (Series A)Consumer Health (Series B)Consumer Health (Seed)Investors who were founders Diverse Investors Investors who invested in diverse founders Investors who invested in female founders Health IT (Series B)BioTech (Series B)Digital Health (Series B)Diagnostics (Pre-seed)Health & Hospital Services (Pre-seed)Generative Tech/AI (Seed)AI (Pre-seed)Consumer Health (Series A)Health & Hospital Services (Series B)Health IT (Pre-seed)AI (Series B)New York City Diagnostics (Series B)Generative Tech/AI (Series B)Diagnostics (Seed)BioTech (Pre-seed)AI (Series A)Consumer Health (Pre-seed)Health IT (Series A)BioTech (Seed)Health & Hospital Services (Seed)Health & Hospital Services (Series A)Health IT (Seed)AI (Seed)Wellness & Fitness (Pre-seed)DeepTech (Seed)Diagnostics (Series A)Digital Health (Seed)Wellness & Fitness (Seed)DeepTech (Series A)Generative Tech/AI (Pre-seed)Generative Tech/AI (Series A)DeepTech (Series B)Digital Health (Pre-seed)Digital Health (Series A)Wellness & Fitness (Series A)Wellness & Fitness (Series B)DeepTech (Pre-seed)

Martin Alexander Gershon's Investments On Record (66)

Company	StageDateRound Size	Total Raised
QuantHealth	Series AAug 2023$2.5M	$18M
Co-investors: Ittai Harel (Pitango Venture Capital), Cris De Luca (Sanofi Ventures)
Viome Life Sciences	Series CAug 2023$10M	$10M
Fertifa	Seed Jun 2023$650K	$7.7M
Co-investors: Malin Posern (Index Ventures), Deepali Nangia (Atomico), Jonathan Lenson (LocalGlobe), Eileen Burbidge (Passion Capital), Adam Knight (Emerge VC), Manuel Antunes (Triple Point Investment Management), Itxaso del Palacio (Notion Capital), Jeremy Yap (Xtripe Angels), Mike Hudack, Tom Blomfield
Alto Neuroscience	Series BJan 2023$7M	$130M
Co-investors: Stephen Hays (What If Ventures), Christian Angermayer (Presight Capital), Michael Liang (Baird Capital), Tim Kendall
PVmed	Series BDec 2022$70K	$70K
BehaVR	Series BDec 2022$1M	$2M
Co-investors: Kelby Price (Kentucky Science and Technology Corporation), Enke Bashllari (Arkitekt Ventures)
SaVia Health	SeedDec 2022$1M	$10M
Co-investors: Jen Ard (Intel Capital), Eric King (Solventum)
Cardiosense	Series ADec 2022$3M	$18M
Co-investors: Daniel Gottlieb (Broadview Ventures), Jeff Terrell (Arboretum Ventures)

Martin Alexander Gershon's Experience

Advisor NYEDC Venture Capital Convening New York City Economic Development CorporationPresent

Moderator, AI4 Conference, AI Diagnostics Ai4 - Artificial Intelligence ConferencesPresent

Featured Speaker on AI, HSBC Health 2035 Summit HSBC Innovation BankingPresent

Moderator AI Precision Medicine Health Summit 1BusinessWorldPresent

Senior Lead Mentor-in-Residence, Techstars TechstarsPresent

Keynote Speaker, AI Summit Endeavor Venture Fund & Venture StudioPresent

Expert for the Nucleate NY Activator NucleatePresent

Speaker, BIO International Convention, Healthcare AI Opportunities and Headwinds Biotechnology Innovation OrganizationPresent

Moderator, BIO International Convention, The Future of AI Healthcare Biotechnology Innovation OrganizationPresent

Keynote Speaker, Informa, AI Healthcare Finance and Integration InformaPresent

Gershon & Company, CEO and Founder RiskGeniusPresent

Managing Partner and CIO, Endeavor Venture Fund I RiskGeniusPresent

Managing Partner and CIO, Endeavor Venture Studio RiskGeniusPresent

Managing Partner and CIO, Endeavor Venture Fund II and Endeavor Venture Studio RiskGeniusPresent

Venture University, Venture Syndicate Investment Partner VU Venture PartnersPresent

MIT CEO Summit on Artificial Intelligence MIT Computer Science and Artificial Intelligence Laboratory (CSAIL)Present

Martin Alexander Gershon's Education

Columbia University in the City of New York Internal Medicine Neuroscience and Neurology Residency

Boston University School of Law Juris Doctorate of Law Specialty Healthcare Law, FDA Regulatory Law, Drug and Device Approvals, Digital Healthcare Law

Boston University School of Public Health Master’s Degree Public Health Specialty Healthcare Law, Biostatistics, Clinical Trial Design, FDA Drug and Device Approvals

Gerstner Sloan-Kettering Graduate School of Biomedical Sciences at Memorial Sloan-Kettering Cancer Center Mayday Fellow Neuroscience, Oncology and Neuroscience of Pain Management, null

Harvard University Graduate School of Arts and Sciences Special Studies Program, Teaching Fellow Teaching Fellow

Harvard University Graduate School of Arts and Sciences Special Studies Program Teaching Fellow, null

Columbia University in the City of New York Internal Medicine Neuroscience and Neurology Residency, null

Gerstner Sloan-Kettering Graduate School of Biomedical Sciences at Memorial Sloan-Kettering Cancer Center Mayday Fellow, Neuroscience, Oncology and Neuroscience of Pain Management Neuroscience, Oncology and Neuroscience of Pain Management

McGill University Doctor of Medicine - MD Neuroscience and Immunology

Investors who invest with Martin Alexander Gershon

Scouts & Angels Affiliated With Martin Alexander Gershon